Form D — Intelligent Therapeutics, Inc.
0002136711-26-000001 · filed May 28, 2026
Offering
- Industry
- Other Technology
- Exemptions
- 06b
- Total offering
- $700,000
- Total sold
- $100,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Intelligent Therapeutics, Inc.
- CIK
- 2136711
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2025
- Address
- 220 EAST 11TH AVENUE SUITE 6
EUGENE, OR 97401 - Phone
- 5412325062
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Jason Gallic · Executive OfficerEugene, OR Find on LinkedIn ↗
-
Nathan Bernstein · Executive OfficerEugene, OR Find on LinkedIn ↗
-
Thomas Emmons · Executive OfficerEugene, OR Find on LinkedIn ↗
-
Michael Zvolensky · Executive OfficerEugene, OR Find on LinkedIn ↗
-
David Shear · DirectorEugene, OR Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗